RFK Jr. aide: GLP-1 weight loss meds will cost the same as in least expensive countries

A key aide to HHS Secretary Robert F. Kennedy Jr. said that popular GLP-1 weight loss drugs — Novo Nordisk’s (NVO) Wegovy (semaglutide) and Eli Lilly’s (NYSE:LLY) Zepbound (tirzepatide) — will cost U.S. consumers the same amount as the lowest amount